Evidence map›Paper›PMID 27196093›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2016

Results of a Multilevel Intervention Trial to Increase Human Papillomavirus (HPV) Vaccine Uptake among Adolescent Girls.

Electra D Paskett, Jessica L Krok-Schoen, Michael L Pennell, Cathy M Tatum, Paul L Reiter, Juan Peng, Brittany M Bernardo, Rory C Weier, Morgan S Richardson, Mira L Katz

3 registry-linked trialsOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 46 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 10 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06290206 nacompletednot on this mapstarted 2024, after this paper: background citation

PREVENT: Practice-based Approaches to Promote HPV Vaccination in the Safety Net - BootCamp Translation

TypeinterventionalSponsorUniversity of UtahRan2024 to 2024Enrolled18ConditionsHPV Vaccination, Vaccine, Uptake, VaccinationArmsPREVENT - BCT
NCT06738355 nacompletednot on this mapstarted 2025, after this paper: background citation

PREVENT: Practice-based Approaches to Promote HPV Vaccination in the Safety Net - Pilot Trial

TypeinterventionalSponsorUniversity of UtahRan2025 to 2025Enrolled335ConditionsHPV Vaccination, Uptake Vaccination, Series CompletionArmsPREVENT
NCT07217145 phase3active not recruitingnot on this mapstarted 2025, after this paper: background citation

PREVENT: Practice-based Approaches to Promote HPV Vaccination in the Safety Net - Randomized Controlled Trial (RCT)

TypeinterventionalSponsorUniversity of UtahRan2025 to 2027Enrolled1,455ConditionsHPV Vaccination, Uptake Vaccination, Series CompletionArmsPREVENT
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 10 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Increasing HPV Vaccination Uptake among Adolescents: A Systematic Review.International journal of environmental research and public health · 2020
    Pooled it
  8. Improving vaccination uptake among adolescents.The Cochrane database of systematic reviews · 2020
    Pooled it
  9. Pooled it
  10. Patient reminder and recall interventions to improve immunization rates.The Cochrane database of systematic reviews · 2018
    Pooled it
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Electra D PaskettComprehensive Cancer Center, The Ohio State University, Columbus, Ohio. Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio. Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio. electra.paskett@osumc.edu.
Jessica L Krok-SchoenComprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Michael L PennellDivision of Biostatistics, College of Public Health, The Ohio State University, Columbus, Ohio.
Cathy M TatumComprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Paul L ReiterComprehensive Cancer Center, The Ohio State University, Columbus, Ohio. Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio. Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio.
Juan PengDivision of Biostatistics, College of Public Health, The Ohio State University, Columbus, Ohio.
Brittany M BernardoComprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
Rory C WeierPartners for Kids, Columbus, Ohio.
Morgan S RichardsonDepartment of Neurology, College of Medicine, The Ohio State University, Columbus, Ohio.
Mira L KatzComprehensive Cancer Center, The Ohio State University, Columbus, Ohio. Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio. Division of Health Behavior and Health Promotion, College of Public Health, The Ohio State University, Columbus, Ohio.
Ohio Department of Health · USThe Ohio State University · USHealthPartners · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
TRAINING AND CAREER DEVELOPMENTP50CA105632 · NCI · OHIO STATE UNIVERSITY · PI PASKETT, ELECTRA D. · 2003 to 2016
$17.2M
NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA105632
6 · The paper itself

Abstract

backgroundUptake of the human papillomavirus (HPV) vaccine is low in Appalachian Ohio and areas with high cervical cancer rates.

methodsWe conducted a group-randomized trial among 12 counties in Appalachian Ohio randomized to receive either an HPV vaccine (intervention counties) or influenza vaccine (comparison counties) multilevel intervention (MLI). Parents (n = 337) who had a daughter aged 9 to 17 years who had not received the HPV vaccine were recruited from commercial lists. Clinics (N = 24) and 119 providers from these clinics were also recruited. The primary outcome was medical record-confirmed receipt of the first shot of the HPV vaccine 3 months after receiving the intervention among daughters of parents enrolled in the study. Secondary outcomes included receipt of the first HPV vaccine shot by 6 months and changes in provider knowledge.

resultsAccording to medical records, 10 (7.7%) daughters of intervention participants received the first shot of the HPV vaccine within 3 months of being sent the intervention materials compared with 4 (3.2%) daughters of comparison group participants (P = 0.061). By 6 months, 17 (13.1%) daughters of intervention participants received the first HPV vaccine shot compared with eight (6.5%) daughters of comparison group participants (P = 0.002). Provider knowledge about HPV increased (P < 0.001, from baseline to after education).

conclusionsThe MLI increased uptake of the HPV vaccine among girls aged 9 to 17 years; however, uptake was low. IMPACT: To improve HPV vaccine uptake, attention to additional levels of influence (e.g., policy, community) and more elements within levels (e.g., reminders, automated prompts) may be needed. Cancer Epidemiol Biomarkers Prev; 25(4); 593-602. ©2016 AACR SEE ALL ARTICLES IN THIS CEBP FOCUS SECTION, "MULTILEVEL APPROACHES TO ADDRESSING CANCER HEALTH DISPARITIES".

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsAdolescentChildFemaleHumansPapillomavirus Vaccines

Identifiers

PMID27196093
PMCPMC4874659
OpenAlexW2317507927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.